BMT
R&D productivity worse than previously reported
February 15, 2011Manufacturing and Production, Research and Development, Sales and Marketing BIO, BMT, FDA, R&D
A new analysis of pharma’s R&D pipelines suggests the overall success rate for drugs moving from clinical trials to FDA …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
